HOLLIE CASHION: Open Payments
NPI 1295289106 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,218 in 97 payments from 19 companies in 2025. Trend: 2023 $1,011 · 2024 $1,710 · 2025 $2,218
Food & beverage: $2,218
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $511 |
| GENZYME CORPORATION | 14 | $412 |
| Amgen Inc. | 10 | $173 |
| GlaxoSmithKline, LLC. | 11 | $150 |
| Optinose US, Inc. | 5 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $99 |
| Grifols USA, LLC | 4 | $82 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xhance, CUVITRU, NUCALA, NEFFY, Xolair.
Industry payments across TN — which companies pay providers there.
